News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
778,697 Results
Type
Article (63703)
Company Profile (710)
Press Release (714255)
Multimedia
Podcasts (174)
Webinars (30)
Section
Business (209163)
Career Advice (3125)
Deals (37038)
Drug Delivery (170)
Drug Development (84685)
Employer Resources (184)
FDA (17877)
Job Trends (16085)
News (359513)
Policy (35990)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (2)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (3)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
Academia (3025)
Academic (1)
Accelerated approval (51)
Adcomms (40)
Allergies (186)
Alliances (54348)
ALS (224)
Alzheimer's disease (1940)
Antibody-drug conjugate (ADC) (505)
Approvals (18187)
Artificial intelligence (762)
Autoimmune disease (322)
Automation (61)
Bankruptcy (380)
Best Places to Work (12451)
BIOSECURE Act (22)
Biosimilars (241)
Biotechnology (434)
Bladder cancer (205)
Brain cancer (81)
Breast cancer (798)
Cancer (6208)
Cardiovascular disease (523)
Career advice (2661)
Career pathing (50)
CAR-T (366)
CDC (72)
Celiac Disease (3)
Cell therapy (998)
Cervical cancer (49)
Clinical research (72916)
Collaboration (2271)
Company closure (7)
Compensation (1278)
Complete response letters (101)
COVID-19 (3007)
CRISPR (119)
C-suite (1218)
Cystic fibrosis (164)
Data (8219)
Decentralized trials (3)
Denatured (58)
Depression (186)
Dermatology (89)
Diabetes (627)
Diagnostics (7459)
Digital health (58)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (361)
Drug pricing (241)
Drug shortages (38)
Duchenne muscular dystrophy (306)
Earnings (87756)
Editorial (71)
Employer branding (23)
Employer resources (164)
Events (120063)
Executive appointments (1161)
FDA (21781)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (35)
Funding (1849)
Gene editing (260)
Generative AI (67)
Gene therapy (812)
GLP-1 (1218)
Government (5361)
Grass and pollen (8)
Guidances (413)
Healthcare (20720)
HIV (88)
Huntington's disease (62)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (102)
Immunology and inflammation (333)
Immuno-oncology (105)
Indications (197)
Infectious disease (3383)
Inflammatory bowel disease (239)
Inflation Reduction Act (17)
Influenza (146)
Intellectual property (304)
Interviews (585)
IPO (17090)
IRA (59)
Job creations (4005)
Job search strategy (2168)
JPM (69)
Kidney cancer (21)
Labor market (100)
Layoffs (644)
Leadership (50)
Legal (8583)
Liver cancer (108)
Longevity (33)
Lung cancer (821)
Lymphoma (440)
Machine learning (63)
Management (63)
Manufacturing (1145)
MASH (207)
Medical device (15016)
Medtech (15150)
Mergers & acquisitions (21222)
Metabolic disorders (1675)
mRNA (251)
Multiple sclerosis (199)
NASH (23)
Neurodegenerative disease (474)
Neuropsychiatric disorders (122)
Neuroscience (3587)
Neurotech (1)
NextGen: Class of 2026 (7427)
Non-profit (5088)
Now hiring (76)
Obesity (812)
Opinion (362)
Ovarian cancer (232)
Pain (276)
Pancreatic cancer (322)
Parkinson's disease (395)
Partnered (36)
Patents (629)
Patient recruitment (709)
Peanut (67)
People (61976)
Pharmaceutical (123)
Pharmacy benefit managers (36)
Phase 1 (22764)
Phase 2 (31995)
Phase 3 (24123)
Pipeline (9160)
Policy (379)
Postmarket research (2644)
Preclinical (10009)
Press Release (71)
Prostate cancer (327)
Psychedelics (64)
Radiopharmaceuticals (356)
Rare diseases (1205)
Real estate (6705)
Recruiting (78)
Regulatory (27885)
Reports (54)
Research institute (2735)
Resumes & cover letters (499)
Rett syndrome (40)
RNA editing (28)
RSV (97)
Schizophrenia (187)
Series A (313)
Series B (228)
Service/supplier (26)
Sickle cell disease (121)
Special edition (30)
Spinal muscular atrophy (181)
Sponsored (55)
Startups (4005)
State (2)
Stomach cancer (20)
Supply chain (140)
Tariffs (101)
The Weekly (114)
Vaccines (1257)
Venture capital (115)
Weight loss (557)
Women's health (130)
Worklife (24)
Date
Last 7 days (695)
Last 30 days (3465)
Last 365 days (31485)
2026 (13635)
2025 (31680)
2024 (37086)
2023 (41851)
2022 (53252)
2021 (57887)
2020 (56950)
2019 (50553)
2018 (38451)
2017 (35307)
2016 (34853)
2015 (40420)
2014 (32931)
2013 (28662)
2012 (30875)
2011 (31157)
2010 (28832)
Location
Africa (1008)
Alabama (102)
Alaska (7)
Arizona (351)
Arkansas (16)
Asia (48162)
Australia (8095)
California (13574)
Canada (3865)
China (1465)
Colorado (583)
Connecticut (601)
Delaware (420)
Europe (106038)
Florida (2039)
Georgia (456)
Hawaii (4)
Idaho (65)
Illinois (1143)
India (98)
Indiana (641)
Iowa (24)
Japan (558)
Kansas (140)
Kentucky (56)
Louisiana (47)
Maine (89)
Maryland (1645)
Massachusetts (9767)
Michigan (401)
Minnesota (770)
Mississippi (7)
Missouri (160)
Montana (37)
Nebraska (28)
Nevada (148)
New Hampshire (91)
New Jersey (3588)
New Mexico (34)
New York (3561)
North Carolina (1869)
North Dakota (11)
Northern California (6704)
Ohio (431)
Oklahoma (26)
Oregon (53)
Pennsylvania (2687)
Puerto Rico (30)
Rhode Island (51)
South America (1377)
South Carolina (88)
South Dakota (2)
Southern California (5341)
Tennessee (219)
Texas (2203)
United States (48526)
Utah (415)
Vermont (1)
Virginia (352)
Washington D.C. (83)
Washington State (1111)
West Virginia (4)
Wisconsin (152)
Wyoming (2)
778,697 Results for "alpha pro tech ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Alpha Pro Tech, Ltd. Announces Fourth Quarter and Full Year 2025 Financial Results
March 12, 2026
·
18 min read
Press Releases
Alpha Pro Tech, Ltd. Announces Third Quarter 2025 Financial Results
November 6, 2025
·
12 min read
Business
Alpha Pro Tech, Ltd. Announces Fourth Quarter and Full Year 2023 Financial Results
Alpha Pro Tech, Ltd., a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building products, announced financial results for the three month period and year ended December 31, 2023.
March 13, 2024
·
18 min read
Business
Alpha Pro Tech, Ltd. Announces Third Quarter 2023 Financial Results
Alpha Pro Tech, Ltd. announced financial results for the three and nine month period ended September 30, 2023.
November 7, 2023
·
18 min read
Press Releases
Alpha Tau Announces 100% Local Disease Control Rate and Favorable Safety Profile Observed in Alpha DaRT® Pancreatic Cancer Trials Presented at DDW 2026
May 4, 2026
·
8 min read
Press Releases
Alpha Tau Announces First Quarter 2026 Financial Results and Provides Corporate Update
May 18, 2026
·
14 min read
Press Releases
Alpha Tau to Participate in May 2026 Investor Conferences
May 18, 2026
·
1 min read
Press Releases
Alpha Tau Announces Groundbreaking Interim Results from its U.S. Alpha DaRT® Recurrent Glioblastoma Trial, with 100% Local Disease Control, 67% Complete Response Rate, and Favorable Safety Profile Observed - Conference Call Scheduled for 8:30am ET
May 11, 2026
·
9 min read
Press Releases
Alpha Tau Successfully Treats First Pancreatic Cancer Patient in Italy with Alpha DaRT® at the University of Verona’s Pancreas Institute
May 7, 2026
·
9 min read
Business
Alpha Pro Tech, Ltd. Announces Second Quarter 2023 Financial Results
Alpha Pro Tech, Ltd., a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building products, announced financial results for the three and six month periods ended June 30, 2023.
August 8, 2023
·
20 min read
1 of 77,870
Next
